Shares of Renishaw plc (LON:RSW) have earned an average recommendation of “Hold” from the eight analysts that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is GBX 3,341.33 ($45.31).
Several equities analysts have recently weighed in on RSW shares. Barclays raised their price target on Renishaw from GBX 3,880 ($52.62) to GBX 4,100 ($55.60) and gave the company an “underweight” rating in a report on Monday, December 18th. Peel Hunt restated a “reduce” rating on shares of Renishaw in a report on Thursday. Numis Securities downgraded Renishaw to a “hold” rating and set a GBX 5,200 ($70.52) price target for the company. in a report on Tuesday, December 5th. Deutsche Bank restated a “sell” rating and set a GBX 3,630 ($49.23) price target on shares of Renishaw in a report on Monday, October 23rd. Finally, Citigroup restated a “neutral” rating and set a GBX 470 ($6.37) price target on shares of Renishaw in a report on Monday, October 30th.
In other Renishaw news, insider Kath Durrant acquired 198 shares of the company’s stock in a transaction that occurred on Thursday, January 25th. The shares were bought at an average cost of GBX 5,035 ($68.28) per share, with a total value of £9,969.30 ($13,519.53).
Renishaw (LON:RSW) last issued its quarterly earnings results on Thursday, January 25th. The company reported GBX 72.70 ($0.99) earnings per share for the quarter. Renishaw had a return on equity of 35.72% and a net margin of 24.64%. The firm had revenue of £279.46 million during the quarter.
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw and related companies with MarketBeat.com's FREE daily email newsletter.